Tag:
Formulation Development
Latest Headlines
Latest Headlines
Endo unveils crush-resistant opioid
The FDA has approved a new formulation of Endo Pharmaceuticals' ( $ENDP ) opioid analgesic, Opana ER, that's intended to resist being crushed. Endo says in a statement that the tablets are based on a
J&J yields to activists on baby-product chemicals
Johnson & Johnson ( $JNJ ) has begun replacing potentially harmful preservatives in some of its baby products. Consumer activists apparently sparked the action. Of particular concern to the
OxyContin abuse overshadows formulation fix
The reformulated version of OxyContin that became available last year appears to be delivering on Purdue's promise of an abuse-fighting trait touted--but not delivered--in the original formulation.
UPDATED: Sanofi licenses hard-to-make allergy drug to Acton
Expertise in aerosol product manufacturing has won startup Acton Pharmaceuticals ($ACTOP) a development and marketing contract from Sanofi U.S. ( $SNY ) that could finally bring to market a drug
OctoPlus lands formulation work
Netherlands-based drug-delivery specialist OctoPlus will perform formulation development and clinical manufacturing for an unnamed mid-sized European drug maker. The work encompasses three products,
